Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin challenge in healthy volunteers
NCT04821323Phase 1Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indomethacin, sponsored by Janssen Pharmaceutical. Primary endpoints: Longitudinal Change From Baseline in Lactulose/Mannitol Ratio in the Urine Following Indomethacin Challenge at 14 days, Number of Participants with Treatment-Emergent Adverse Events at 6 weeks and 1 more. Started Mar 2021; status: completed.
02
Drugs
indomethacin
Beyond the preview
Go deeper on NCT04821323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821323.